GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Antibiotice SA (BSE:ATB) » Definitions » ROE % Adjusted to Book Value

Antibiotice (BSE:ATB) ROE % Adjusted to Book Value : 1.99% (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Antibiotice ROE % Adjusted to Book Value?

Antibiotice's ROE % for the quarter that ended in Dec. 2023 was 2.21%. Antibiotice's PB Ratio for the quarter that ended in Dec. 2023 was 1.11. Antibiotice's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 1.99%.


Antibiotice ROE % Adjusted to Book Value Historical Data

The historical data trend for Antibiotice's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antibiotice ROE % Adjusted to Book Value Chart

Antibiotice Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.29 8.58 7.55 15.00 9.20

Antibiotice Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.12 22.59 34.64 7.53 1.99

Competitive Comparison of Antibiotice's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Antibiotice's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Antibiotice's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Antibiotice's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Antibiotice's ROE % Adjusted to Book Value falls into.



Antibiotice ROE % Adjusted to Book Value Calculation

Antibiotice's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=10.21% / 1.11
=9.20%

Antibiotice's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=2.21% / 1.11
=1.99%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Antibiotice ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Antibiotice's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Antibiotice (BSE:ATB) Business Description

Traded in Other Exchanges
N/A
Address
1 Valea Lupului Street, Iasi, ROU, 707410
Antibiotice Ord is a Romania based company engaged in manufacturing generic medicines. It primarily develops and produces generic medicines for human use, veterinary medicines and active substance Nystatin. The group's generic medicines are primarily targeted at patients with infections, dermatological, cardiovascular, digestive tract diseases or diseases of the musculoskeletal system. It manufactures firm powders for solutions for injection and suspensions for injection (penicillins), capsules, tablets, suppositories and topical preparations (ointments, gels, creams).

Antibiotice (BSE:ATB) Headlines

No Headlines